The University of Chicago Header Logo

Connection

Hedy Kindler to Erlotinib Hydrochloride

Back to Details
This is a "connection" page, showing publications Hedy Kindler has written about Erlotinib Hydrochloride.
Hedy Kindler
Connection Strength
0.152
Erlotinib Hydrochloride
  1. Pancreatic cancer: an update. Curr Oncol Rep. 2007 May; 9(3):170-6.
    View in: PubMed
    Score: 0.072
  2. Perioperative Gemcitabine?+?Erlotinib Plus Pancreaticoduodenectomy for Resectable Pancreatic Adenocarcinoma: ACOSOG Z5041 (Alliance) Phase II Trial. Ann Surg Oncol. 2019 Dec; 26(13):4489-4497.
    View in: PubMed
    Score: 0.042
  3. Erlotinib plus bevacizumab in previously treated patients with malignant pleural mesothelioma. Cancer. 2008 Aug 15; 113(4):808-14.
    View in: PubMed
    Score: 0.020
  4. Phase I and pharmacokinetic study of erlotinib for solid tumors in patients with hepatic or renal dysfunction: CALGB 60101. J Clin Oncol. 2007 Jul 20; 25(21):3055-60.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.